Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimonabant for Smoking Cessation (STRATUS-META)
NCT00464256Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2004
- Primary completion
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rimonabant in Tobacco Use Disorder (TUD), sponsored by Sanofi. Started Apr 2004; status: completed.
02
Drugs
rimonabant
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00464256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00464256.